Compounded semaglutide, the same active ingredient studied in GLP-1 research, with a 5-step titration protocol guided by your provider.
Injectable from $79/mo with 12-month plan · oral from $199/moPlan availability and pricing vary by state. California has its own pricing, confirmed during your assessment.

Semaglutide is the GLP-1 receptor agonist studied in large clinical trials for chronic weight management, individual results vary.
Start low and increase gradually across 5 steps (0.25mg up to 2.5mg weekly) to support tolerability while your body adjusts.
Weekly subcutaneous injection with B-vitamin co-formulation, or daily rapid-dissolve tablet for needle-free dosing.
Licensed providers review your health history, prescribe when appropriate, and adjust your protocol as you progress.
Dosing starts low and increases gradually. Your provider adjusts each step based on your response and tolerability.
Semaglutide is a GLP-1 receptor agonist. GLP-1 is a hormone involved in appetite signaling and gastric emptying, and semaglutide has been studied for its role in appetite and digestion.
A 5-minute online health questionnaire, no appointment, no waiting room.
A licensed provider in your state reviews your history and prescribes if appropriate.
Your medication ships from a licensed U.S. pharmacy in discreet packaging.
Message your care team anytime. Dose questions, refill reviews, and adjustments are handled online when clinically appropriate.
Your assessment takes about 5 minutes. A licensed provider takes it from there.
Compounded tirzepatide is designed to act on both GIP and GLP-1 receptor pathways, with a 6-step titration…